Stanker James H
SEC CIK 1681718 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | CFO | 6,764 | — | — | 10 | 2021-08-05 | 2024-04-05 |
Most active insiders at PCSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ng George K | CEO, Dir | $55.0K | — |
| 2 | SKIBSTED RUSSELL | CFO | $41.7K | — |
| 3 | Guy Wendy | Chief Administrative Off | $32.9K | — |
| 4 | Young David | Pres. Research, Development, Dir | $32.4K | — |
| 5 | Lin Patrick | Chief Business - Strategy Off | $28.5K | — |
| 6 | Bigora Sian | Chief Development Off | $21.4K | — |
| 7 | Baluch Khoso | Dir | $5,752 | — |
| 8 | Pannu Geraldine | Dir | $5,253 | — |
| 9 | Neal James R | Dir | $2,000 | — |
| 10 | Yorke Justin W | Dir | — | — |
Stanker James H made no open-market trades at PCSA in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-02 | 2024-04-05+ | PCSA | Processa Pharmaceuticals, Inc. | Stanker James H | CFO | M - OptEx | — | +2,319 | 6,764 | +52% | — |
| DM | 2024-08-02 | 2024-04-05+ | PCSA | Processa Pharmaceuticals, Inc. | Stanker James H | CFO | F - Tax | $2.41 | -800 | 6,482 | -11% | -$1,927 |
| D | 2024-04-12 | 2024-01-01 | PCSA | Processa Pharmaceuticals, Inc. | Stanker James H | CFO | M - OptEx | — | +1,675 | 6,638 | +34% | — |
| D | 2024-04-12 | 2024-01-01 | PCSA | Processa Pharmaceuticals, Inc. | Stanker James H | CFO | F - Tax | $2.79 | -518 | 6,120 | -8% | -$1,445 |
| 2023-10-12 | 2023-10-12 | PCSA | Processa Pharmaceuticals, Inc. | Stanker James H | CFO | A - Grant | $0.33 | +15.0K | 99.2K | +18% | +$4,950 | |
| 2023-10-10 | 2023-10-10 | PCSA | Processa Pharmaceuticals, Inc. | Stanker James H | CFO | A - Grant | $0.24 | +22.5K | 84.2K | +36% | +$5,400 | |
| 2023-02-10 | 2023-02-09 | PCSA | Processa Pharmaceuticals, Inc. | Stanker James H | CFO | A - Grant | $0.8 | +12.5K | 61.8K | +25% | +$10.0K | |
| 2022-08-09 | 2022-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Stanker James H | CFO | F - Tax | $3.17 | -2,462 | 49.2K | -5% | -$7,805 | |
| 2022-08-09 | 2022-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Stanker James H | CFO | M - OptEx | — | +7,601 | 51.7K | +17% | — | |
| 2021-08-09 | 2021-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Stanker James H | CFO | A - Grant | — | +7,601 | 44.1K | +21% | — |
Purchase Sale Sale after option exercise All abbreviations